Larvol Delta - Understanding-the-Assumptions-on-Anifrolumab-Dose-Regimen-Selection-for-a-Phase-3-Trial-in-Lupus-Nephritis

Saphnelo (anifrolumab-fnia) - AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/42775706

Rajesh Krishna

Sep 24, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next